Figure 2.(a)Results of the Monte-Carlo simulations describing a population of elderly patients after a single oral dose of propranolol.-The Brain and Propranolol Pharmacokinetics in the Elderly
| Main Authors: | Andy R. Eugene, Wayne T. Nicholson |
|---|---|
| Format: | info Image |
| Bahasa: | eng |
| Terbitan: |
, 2015
|
| Subjects: | |
| Online Access: |
https://www.edusoft.ro/brain/index.php/brain/issue/view/30 |
Daftar Isi:
- In effort to identify the recommended Propranolol dosage for elderly patients, we identified the patient package inserts from the Food and Drug Administration (FDA) Inderal label, who manufacture propranolol. Based from FDA Wyeth Propranolol label, for dosing in the geriatric population,the label states that there were not sufficient numbers of clinical study participants who were 65-years and older to properly determine the difference in response young and elderly patients.